BioSpace News Archive

Nebraska Innovation Campus has announced a new partner. Dan Duncan, NIC’s executive director, said Celerion will move into this space on the campus in February of 2020.

David Roth, Chief Financial Officer of 4basebio AG, comments: “4basebio can now successfully acquire the desired number of shares in full.

Mirum Pharmaceuticals, Inc. announced that company management will participate at the following conferences in February and March.

Viracta Therapeutics, Inc. announced that Ivor Royston, M.D., the Company’s President and CEO, will present an overview of Viracta’s approach in treating patients with Epstein-Barr Virus -associated malignancies and data from the ongoing Phase 2 clinical trial in lymphoma.

Heron Therapeutics, Inc. announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at 1:00 p.m. ET at the Lotte New York Palace hotel.

Dicerna Pharmaceuticals, Inc. announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate overview at two upcoming investor conferences

Amedisys, Inc. reported its financial results for the three month period and year ended December 31, 2019.

VolitionRx Limited announced it will host a conference call on Friday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunction with the filing of its annual report on Form 10-K for the fourth quarter and full year ended December 31, 2019.

First conditional approval of ZYNTEGLOTM (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have β0/β0 genotype in Europe achieved in 2019; Germany launch underway

Agilent Technologies Inc. reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year.